Nyxoah SA Form 6-K Summary
Business context and reporting period
Nyxoah SA, a Belgian medical technology company, furnished this Form 6-K for March 2022. The filing was submitted on March 16, 2022, and reports that the company issued a press release on March 14, 2022.
The filing attaches the March 14 press release as Exhibit 99.1. The provided filing text does not include the substance of that press release.
Financial metrics
The provided filing text does not provide clear values for revenue, profit or loss, cash flow, margins, debt, liquidity, operating expenses, cash balances, or other financial metrics.
Material changes and outlook
The filing text does not describe material changes versus a prior comparable period, guidance, management outlook, risks, contingencies, or unusual items. Any such information may be contained in the referenced Exhibit 99.1, which is not included in the source text.
Filing status
- The report was filed under Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934.
- Nyxoah SA indicated that it files annual reports on Form 20-F.
- The attached press release is furnished and is not deemed filed for purposes of Section 18 of the Exchange Act, unless otherwise specifically incorporated by reference.
Key facts for investors to verify
- Obtain and review Exhibit 99.1, the March 14, 2022 press release.
- Verify whether the press release contains financial results, operating updates, regulatory developments, financing information, or revised guidance.
- Confirm any reported risks, contingencies, liquidity needs, or unusual items in the complete exhibit.